← Back to all trials
Not Yet Recruiting
NCT07662200
A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy
Conditions: Germ Cell Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: EARLY_PHASE1
Enrollment: 10
Sponsor: Ottawa Hospital Research Institute
Location: Ottawa Hospital Cancer Centre Ottawa Ontario
Summary
This is a single-site, open-label, randomized pilot feasibility study conducted at The Ottawa Hospital Cancer Centre. A total of 10 participants will be randomized 1:1 to either the experimental or control arm.
The purpose of this study is to evaluate recruitment capability, intervention adherence, data completeness, and safety prior to consideration of a potential future multi-centre randomized trial.
Eligibility Criteria
1. Diagnosis of germ cell cancer
2. Indication for outpatient treatment using a standard 5-day cisplatin-based chemotherapy regimen
Source: ClinicalTrials.gov (NCT07662200). StuddyBuddy aggregates publicly available trial information.
